GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 26 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $71,000 | -28.3% | 25,404 | -22.2% | 0.00% | – |
| Q2 2021 | $99,000 | -47.3% | 32,634 | -40.5% | 0.00% | -100.0% |
| Q1 2021 | $188,000 | +189.2% | 54,884 | +161.2% | 0.00% | – |
| Q4 2020 | $65,000 | -23.5% | 21,010 | -12.5% | 0.00% | -100.0% |
| Q3 2020 | $85,000 | -28.6% | 24,024 | -30.1% | 0.00% | -66.7% |
| Q1 2020 | $119,000 | +101.7% | 34,350 | +238.9% | 0.00% | – |
| Q4 2019 | $59,000 | -46.4% | 10,135 | -37.0% | 0.00% | -100.0% |
| Q4 2018 | $110,000 | -74.5% | 16,100 | -49.3% | 0.00% | -80.0% |
| Q3 2018 | $431,000 | – | 31,728 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,832,484 | $13,469,000 | 1.47% |
| Knoll Capital Management, LLC | 206,099 | $1,515,000 | 1.24% |
| 683 Capital Management, LLC | 1,350,000 | $9,923,000 | 0.90% |
| Vivo Capital, LLC | 971,337 | $7,139,000 | 0.67% |
| P.A.W. CAPITAL CORP | 70,000 | $515,000 | 0.56% |
| Ibex Investors LLC | 807,400 | $5,934,000 | 0.48% |
| MEITAV INVESTMENT HOUSE LTD | 639,269 | $4,693,000 | 0.31% |
| Nantahala Capital Management | 879,200 | $6,559,000 | 0.20% |
| Rock Creek Group, LP | 57,201 | $420,000 | 0.19% |
| FIRST MIDWEST BANK TRUST DIVISION | 164,847 | $1,212,000 | 0.17% |